Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides

Details for Australian Patent Application No. 2005338050 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar R.; Agrawal, Sudhir; Yu, Dong

Agent Freehills

Pub. Number AU-B-2005338050

PCT Pub. Number WO2007/055682

Filing date 7 November 2005

Wipo publication date 18 May 2007

Acceptance publication date 2 February 2012

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/055682 Priority application(s): WO2007/055682

3 July 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Idera Pharmaceuticals, Inc., Application No. 2005338050, Under INID (71), correct the name to Idera Pharmaceuticals.

21 August 2008 Alteration of Name

  The name of the applicant has been altered to Idera Pharmaceuticals, Inc. 2006

2 February 2012 Application Accepted

  Published as AU-B-2005338050

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005338055-Microprojectile bombardment transformation of Brassica

2005338035-Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides